Greenwich LifeSciences reports 70% reduction in recurrence rate
Greenwich LifeSciences (NASDAQ:GLSI) amended its Phase III breast cancer trial, expecting a 2.22x overall enrollment increase.
Greenwich LifeSciences (NASDAQ:GLSI) amended its Phase III breast cancer trial, expecting a 2.22x overall enrollment increase.
Seer (NASDAQ:SEER) announced its Special Committee rejected a $2.45 per share acquisition proposal from CEO Omid Farokhzad.
Investar Holding (NASDAQ:ISTR) reported a second quarter 2026 net income of $8.9 million, resulting in $0.61 per diluted share.
Boeing (NYSE:BA) announced that SMBC Aviation Capital ordered 100 737 MAX airplanes to expand its commercial leasing portfolio.
Boeing (NYSE:BA) announced that Riyadh Air will exercise options for 28 additional 787 Dreamliner aircraft and purchase 11 previously unidentified widebody jets.
Kandi Technologies (NASDAQ:KNDI) secured a procurement order from QIJI Energy to equip 18 heavy-truck battery swap stations.
ING Groep (NYSE:ING) reported that Strait of Hormuz liquefied natural gas exports halted, driving regional prices up 25%.
BW LPG (NYSE:BWLP) agreed to sell the 2015-built BW Levant for an expected $17 million net book gain.
Ryanair (NASDAQ:RYAAY) reported a 34% drop in quarterly profit to €538 million amid doubled jet fuel prices.
Lockheed Martin (NYSE:LMT) introduced the PAC-3 Adapted Capability Effector to intercept aerial threats at half the previous cost.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas